Proton Pump Inhibitor Use in the U.S. Ambulatory Setting, 2002-2009

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Rotman, Stephen R ^a   Bishop, Tara F ^b  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; ESOMEPRAZOLE; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; NIZATIDINE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE; RANITIDINE;

ADULT; AGED; AMBULATORY CARE; ARTICLE; CLINICAL ARTICLE; DRUG INDICATION; DRUG UTILIZATION; FEMALE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; HUMAN; MALE; MEDICAL PRACTICE; OUTPATIENT CARE; PRESCRIPTION; TREND STUDY; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; FEMALE; HEALTH CARE SURVEYS; HUMANS; MALE; MIDDLE AGED; PROTON PUMP INHIBITORS; UNITED STATES;

EID: 84873925644     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056060     Document Type: Article

References (31)

1. Korenstein D, Falk R, Howell EA, Bishop T, Keyhani S, (2012) Overuse of health care services in the United States: an understudied problem. Arch Intern Med 172(2): 171-178.
2. Keyhani S, Falk R, Bishop T, Howell E, Korenstein D, (2012) The relationship between geographic variations and overuse of healthcare services: a systematic review. Med Care 50(3): 257-261.
3. Gottlieb DJ, Zhou W, Song Y, Andrews KG, Skinner JS, et al. (2010) Prices don't drive regional Medicare spending variations. Health Aff (Millwood) 29(3): 537-543.
4. Sutherland JM, Fisher ES, Skinner JS, (2009) Getting past denial-the high cost of health care in the United States. N Engl J Med 361(13): 1227-1230.
5. National Committee for Quality Assurance (2007) The Essential Guide to Healthcare Quality. Available: http://www.ncqa.org/Portals/0/Publications/Resource%20Library/NCQA_Primer_web.pdf. Accessed 2012 Mar 15.
6. Institute of Medicine (2001) Crossing the Quality Chasm: A New Health System for the Twenty-first Century. Washington: National Academy Press.
7. Agency for Healthcare Research and Quality website. Understanding healthcare quality. Available: http://www.ahrq.gov/consumer/guidetoq/guidetoq4.htm. Accessed 2012 Mar 15.
8. George CJ, Korc B, Ross JS, (2008) Appropriate proton pump inhibitor use among older adults: a retrospective chart review. Am J Geriatr Pharmacother 6(5): 249-254.
9. Hollingworth S, Duncan EL, Martin JH, (2010) Marked increase in proton pump inhibitors use in Australia. Pharmacoepidemiol Drug Saf 19(10): 1019-1024.
10. Barozzi N, Tett SE, (2009) Gastroprotective drugs in Australia: utilization patterns between 1997 and 2006 in relation to NSAID prescribing. Clin Ther 31(4): 849-861.
11. Polinski JM, Donohue JM, Kilabuk E, Shrank WH, (2011) Medicare Part D's effect on the under- and overuse of medications: a systematic review. J Am Geriatr Soc 59(10): 1922-1933.
12. Heidelbaugh JJ, Goldberg KL, Inadomi JM, (2010) Magnitude and economic effect of overuse of antisecretory therapy in the ambulatory care setting. Am J Manag Care 16(9): e228-234.
13. Friedenberg FK, Hanlon A, Vanar V, Nehemia D, Mekapati J, et al. (2010) Trends in gastroesophageal reflux disease as measured by the National Ambulatory Medical Care Survey. Dig Dis Sci 55(7): 1911-1917.
14. Arasaradnam RP, Woodward T, Parrack L, Bartlett J, Bolton RP, (2003) Audit of proton pump inhibitor (PPI) prescribing: are NICE guidelines being followed? Clin Med 3(4): 387-388.
15. Chen TJ, Chou LF, Hwang SJ, (2003) Trends in prescribing proton pump inhibitors in Taiwan: 1997-2000. Int J Clin Pharmacol Ther 41(5): 207-212.
16. Bavishi C, Dupont HL, (2011) Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection. Aliment Pharmacol Ther 34(11-12): 1269-1281.
17. Canani RB, Cirillo P, Roggero P, Romano C, Malamisura B, et al. (2006) Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children. Pediatrics 117(5): e817-820.
18. Gray SL, LaCroix AZ, Larson J, Robbins J, Cauley JA, et al. (2010) Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative. Arch Intern Med 170(9): 765-771.
19. Herzig SJ, Howell MD, Ngo LH, Marcantonio ER, (2009) Acid-suppressive medication use and the risk for hospital-acquired pneumonia. JAMA 301(20): 2120-2128.
20. Howell MD, Novack V, Grgurich P, Soulliard D, Novack L, et al. (2010) Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Arch Intern Med 170(9): 784-790.
21. Kantorova I, Svoboda P, Scheer P, Doubek J, Rehorkova D, et al. (2004) Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial. Hepatogastroenterology 51(57): 757-761.
22. Laheij RJ, Sturkenboom MC, Hassing RJ, Dieleman J, Stricker BH, et al. (2004) Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA 292(16): 1955-1960.
23. Leonard J, Marshall JK, Moayyedi P (2007) Systematic review of the risk of enteric infection in patients taking acid suppression. Am J Gastroenterol 102(9): 2047-2056; quiz 2057.
24. Yang YX, Lewis JD, Epstein S, Metz DC, (2006) Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 296(24): 2947-2953.
25. Yu EW, Bauer SR, Bain PA, Bauer DC, (2011) Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies. Am J Med 124(6): 519-526.
26. Centers for Disease Control and Prevention website. NAMCS scope and sample design. Available: http://www.cdc.gov/nchs/ahcd/ahcd_scope.htm#namcs_scope. Accessed 2012 Mar 8.
27. Centers for Disease Control and Prevention website. NAMCS estimation procedures. Available: http://www.cdc.gov/nchs/ahcd/ahcd_estimation_procedures.htm#namcs_procedures. Accessed 2012 Mar 8.
28. U.S. Food and Drug Administration website. Available: www.fda.gov. Accessed 2012 Jun 29.
29. Lanza FL, Chan FK, Quigley EM, (2009) Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol 104(3): 728-738.
30. Astra Zeneca Nexium Consumer website. Avalable: http://www.purplepill.com/. Accessed 2012 Jun 29.
31. van der Velden AW, de Wit NJ, Quartero AO, Grobbee DE, Numans ME, (2010) Pharmacological dependency in chronic treatment of gastroesophageal reflux disease: a randomized controlled clinical trial. Digestion 81(1): 43-52.